Report Detail

Pharma & Healthcare Global Adult Vaccine Market Insights and Forecast to 2026

  • RnM4128320
  • |
  • 12 August, 2020
  • |
  • Global
  • |
  • 115 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Adult Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Adult Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Adult Vaccine market is segmented into
Influenza
Cervical Cancer
Zoster Shingles
Pneumococcal
Meningococcal
MMRV
Hepatitis
DTP
Travel and Miscellaneous

Segment by Application, the Adult Vaccine market is segmented into
Hospitals
Medical Care Centers
Other

Regional and Country-level Analysis
The Adult Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Adult Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Adult Vaccine Market Share Analysis
Adult Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Adult Vaccine business, the date to enter into the Adult Vaccine market, Adult Vaccine product introduction, recent developments, etc.

The major vendors covered:
GlaxoSmithKline
Sanofi Pasteur
Merck
Novartis
Pfizer
BioCSL (Seqirus)
Protein Sciences
...


1 Study Coverage

  • 1.1 Adult Vaccine Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Adult Vaccine Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Adult Vaccine Market Size Growth Rate by Type
    • 1.4.2 Influenza
    • 1.4.3 Cervical Cancer
    • 1.4.4 Zoster Shingles
    • 1.4.5 Pneumococcal
    • 1.4.6 Meningococcal
    • 1.4.7 MMRV
    • 1.4.8 Hepatitis
    • 1.4.9 DTP
    • 1.4.10 Travel and Miscellaneous
  • 1.5 Market by Application
    • 1.5.1 Global Adult Vaccine Market Size Growth Rate by Application
    • 1.5.2 Hospitals
    • 1.5.3 Medical Care Centers
    • 1.5.4 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Adult Vaccine Market Size, Estimates and Forecasts
    • 2.1.1 Global Adult Vaccine Revenue 2015-2026
    • 2.1.2 Global Adult Vaccine Sales 2015-2026
  • 2.2 Global Adult Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Adult Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Adult Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Adult Vaccine Competitor Landscape by Players

  • 3.1 Adult Vaccine Sales by Manufacturers
    • 3.1.1 Adult Vaccine Sales by Manufacturers (2015-2020)
    • 3.1.2 Adult Vaccine Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Adult Vaccine Revenue by Manufacturers
    • 3.2.1 Adult Vaccine Revenue by Manufacturers (2015-2020)
    • 3.2.2 Adult Vaccine Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Adult Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Adult Vaccine Revenue in 2019
    • 3.2.5 Global Adult Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Adult Vaccine Price by Manufacturers
  • 3.4 Adult Vaccine Manufacturing Base Distribution, Product Types
    • 3.4.1 Adult Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Adult Vaccine Product Type
    • 3.4.3 Date of International Manufacturers Enter into Adult Vaccine Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Adult Vaccine Market Size by Type (2015-2020)
    • 4.1.1 Global Adult Vaccine Sales by Type (2015-2020)
    • 4.1.2 Global Adult Vaccine Revenue by Type (2015-2020)
    • 4.1.3 Adult Vaccine Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Adult Vaccine Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Adult Vaccine Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Adult Vaccine Revenue Forecast by Type (2021-2026)
    • 4.2.3 Adult Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Adult Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Adult Vaccine Market Size by Application (2015-2020)
    • 5.1.1 Global Adult Vaccine Sales by Application (2015-2020)
    • 5.1.2 Global Adult Vaccine Revenue by Application (2015-2020)
    • 5.1.3 Adult Vaccine Price by Application (2015-2020)
  • 5.2 Adult Vaccine Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Adult Vaccine Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Adult Vaccine Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Adult Vaccine Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Adult Vaccine by Country
    • 6.1.1 North America Adult Vaccine Sales by Country
    • 6.1.2 North America Adult Vaccine Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Adult Vaccine Market Facts & Figures by Type
  • 6.3 North America Adult Vaccine Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Adult Vaccine by Country
    • 7.1.1 Europe Adult Vaccine Sales by Country
    • 7.1.2 Europe Adult Vaccine Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Adult Vaccine Market Facts & Figures by Type
  • 7.3 Europe Adult Vaccine Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Adult Vaccine by Region
    • 8.1.1 Asia Pacific Adult Vaccine Sales by Region
    • 8.1.2 Asia Pacific Adult Vaccine Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Adult Vaccine Market Facts & Figures by Type
  • 8.3 Asia Pacific Adult Vaccine Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Adult Vaccine by Country
    • 9.1.1 Latin America Adult Vaccine Sales by Country
    • 9.1.2 Latin America Adult Vaccine Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Adult Vaccine Market Facts & Figures by Type
  • 9.3 Central & South America Adult Vaccine Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Adult Vaccine by Country
    • 10.1.1 Middle East and Africa Adult Vaccine Sales by Country
    • 10.1.2 Middle East and Africa Adult Vaccine Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Adult Vaccine Market Facts & Figures by Type
  • 10.3 Middle East and Africa Adult Vaccine Market Facts & Figures by Application

11 Company Profiles

  • 11.1 GlaxoSmithKline
    • 11.1.1 GlaxoSmithKline Corporation Information
    • 11.1.2 GlaxoSmithKline Description and Business Overview
    • 11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 GlaxoSmithKline Adult Vaccine Products Offered
    • 11.1.5 GlaxoSmithKline Related Developments
  • 11.2 Sanofi Pasteur
    • 11.2.1 Sanofi Pasteur Corporation Information
    • 11.2.2 Sanofi Pasteur Description and Business Overview
    • 11.2.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Sanofi Pasteur Adult Vaccine Products Offered
    • 11.2.5 Sanofi Pasteur Related Developments
  • 11.3 Merck
    • 11.3.1 Merck Corporation Information
    • 11.3.2 Merck Description and Business Overview
    • 11.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Merck Adult Vaccine Products Offered
    • 11.3.5 Merck Related Developments
  • 11.4 Novartis
    • 11.4.1 Novartis Corporation Information
    • 11.4.2 Novartis Description and Business Overview
    • 11.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Novartis Adult Vaccine Products Offered
    • 11.4.5 Novartis Related Developments
  • 11.5 Pfizer
    • 11.5.1 Pfizer Corporation Information
    • 11.5.2 Pfizer Description and Business Overview
    • 11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Pfizer Adult Vaccine Products Offered
    • 11.5.5 Pfizer Related Developments
  • 11.6 BioCSL (Seqirus)
    • 11.6.1 BioCSL (Seqirus) Corporation Information
    • 11.6.2 BioCSL (Seqirus) Description and Business Overview
    • 11.6.3 BioCSL (Seqirus) Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 BioCSL (Seqirus) Adult Vaccine Products Offered
    • 11.6.5 BioCSL (Seqirus) Related Developments
  • 11.7 Protein Sciences
    • 11.7.1 Protein Sciences Corporation Information
    • 11.7.2 Protein Sciences Description and Business Overview
    • 11.7.3 Protein Sciences Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Protein Sciences Adult Vaccine Products Offered
    • 11.7.5 Protein Sciences Related Developments
  • 11.1 GlaxoSmithKline
    • 11.1.1 GlaxoSmithKline Corporation Information
    • 11.1.2 GlaxoSmithKline Description and Business Overview
    • 11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 GlaxoSmithKline Adult Vaccine Products Offered
    • 11.1.5 GlaxoSmithKline Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Adult Vaccine Market Estimates and Projections by Region
    • 12.1.1 Global Adult Vaccine Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Adult Vaccine Revenue Forecast by Regions 2021-2026
  • 12.2 North America Adult Vaccine Market Size Forecast (2021-2026)
    • 12.2.1 North America: Adult Vaccine Sales Forecast (2021-2026)
    • 12.2.2 North America: Adult Vaccine Revenue Forecast (2021-2026)
    • 12.2.3 North America: Adult Vaccine Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Adult Vaccine Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Adult Vaccine Sales Forecast (2021-2026)
    • 12.3.2 Europe: Adult Vaccine Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Adult Vaccine Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Adult Vaccine Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Adult Vaccine Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Adult Vaccine Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Adult Vaccine Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Adult Vaccine Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Adult Vaccine Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Adult Vaccine Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Adult Vaccine Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Adult Vaccine Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Adult Vaccine Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Adult Vaccine Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Adult Vaccine Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Adult Vaccine Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Adult Vaccine Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Summary:
    Get latest Market Research Reports on Adult Vaccine. Industry analysis & Market Report on Adult Vaccine is a syndicated market report, published as Global Adult Vaccine Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Adult Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,053.70
    4,580.55
    6,107.40
    3,588.00
    5,382.00
    7,176.00
    612,456.00
    918,684.00
    1,224,912.00
    324,441.00
    486,661.50
    648,882.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report